Showing results (171-180 of 232) with videos related to
Sort By:
Pageof 24
The New England Journal of Medicine|August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and deathMark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult PatientsNicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.Haematologica|September 24, 2016
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromesAndrew S Artz, Brent Logan, Xiaochun Zhu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 2, 2014
TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521)Gregory A Yanik, Stephan A Grupp, Michael A Pulsipher, et al.Blood|April 21, 2023
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemiaAmy E DeZern, Marianna Zahurak, Heather J Symons, et al.Science Translational Medicine|April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skinSophie Paczesny, Thomas M Braun, John E Levine, et al.Nature Communications|September 12, 2018
Microbial metabolite sensor GPR43 controls severity of experimental GVHDHideaki Fujiwara, Melissa D Docampo, Mary Riwes, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2018
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow TransplantationYvette L Kasamon, Ephraim J Fuchs, Marianna Zahurak, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2025
Glucagon-like peptide-1 receptor signaling deficiency exacerbates hematopoietic stem cell graft rejection in miceMark Rusznak, Daniela Sierra-Hernandez, Catherine Dupuy, et al.Pageof 24